"The local doctors have been taught and trained to diagnose and prescribe treatments for hepatitis C, so the necessity for me to go there is a little less, but I still go there to be a resource and for perhaps more complicated cases,"

CBC NewsProvincial funding for hepatitis C drugs a game changer, health professionals say

"These studies show that there is generalization of the patient population, which should encourage nonacademic physicians to consider treatment for HCV infection because of the very good response rates."

MedscapeA Canadian Thought Leader Perspective From Paul J. Marotta

Our results showed that patients undergoing interferon-based treatment taking cyclosporine have significantly better odds of presenting a sustained viral response (66.7%) compared to tacrolimus (52.8%)

Annals of Hepatology JournalCanadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus

Overall costs are lower compared with sorafenib, while health benefits are greater, with modeled progression-free and overall survival extended by 4.1 and 2.6 months in the lenvatinib arm, respectively.

Canadian Journal of Gastroenterology and HepatologyThe Cost-Effectiveness of Lenvatinib in the Treatment of Advanced or Unresectable Hepatocellular Carcinoma from a Canadian Perspective